This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mylan Gmbh. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Benjamin Che
Introduction
Benjamin Che is an accomplished inventor based in Canonsburg, PA (US). He has made significant strides in the field of medical technology, particularly with his innovative medication reminder system. His work aims to enhance patient adherence to prescribed medication regimens, ultimately improving health outcomes.
Latest Patents
Benjamin Che holds a patent for a "Medical home reminder unit and system." This medication reminder system comprises a controller device that transmits and receives data representing a dosage regimen for medication. The system utilizes medication indicia that contacts a container holding the medication. The medication indicia includes a transmitter that sends data to the controller device, confirming adherence to the dosage regimen. The controller device is designed to display an indicator representing the dosage regimen or a related parameter. This invention showcases Che's commitment to leveraging technology for better healthcare solutions.
Career Highlights
Benjamin Che is currently employed at Mylan GmbH, a global healthcare company known for its focus on generic and specialty pharmaceuticals. His role at Mylan allows him to contribute to the development of innovative healthcare solutions that address patient needs. His patent reflects his dedication to improving medication management for patients.
Collaborations
Benjamin has collaborated with notable colleagues, including Eric William Starr and Molly Knewtson. These partnerships have likely fostered a creative environment that encourages the development of groundbreaking healthcare technologies.
Conclusion
In summary, Benjamin Che is a notable inventor whose work in medication reminder systems exemplifies the intersection of technology and healthcare. His contributions are vital in promoting better adherence to medication regimens, ultimately benefiting patients and healthcare providers alike.
